BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

182 related articles for article (PubMed ID: 12254)

  • 1. Deficiency of NADPH oxidase activity in chronic granulomatous disease.
    McPhail LC; DeChatelet LR; Shirley PS; Wilfert C; Johnston RB; McCall CE
    J Pediatr; 1977 Feb; 90(2):213-7. PubMed ID: 12254
    [TBL] [Abstract][Full Text] [Related]  

  • 2. NADPH oxidase deficiency in X-linked chronic granulomatous disease.
    Hohn DC; Lehrer RI
    J Clin Invest; 1975 Apr; 55(4):707-13. PubMed ID: 235560
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Allosteric transformation of reduced nicotinamide adenine dinucleotide (phosphate) oxidase induced by phagocytosis in human polymorphonuclear leukocytes.
    DeChatelet LR; Shirley PS; McPhail LC; Iverson DB; Doellgast GJ
    Infect Immun; 1978 May; 20(2):398-405. PubMed ID: 27457
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Editorial: Microbial killing by neutrophils.
    Lancet; 1976 Jun; 1(7974):1393-4. PubMed ID: 59024
    [No Abstract]   [Full Text] [Related]  

  • 5. Leukocyte glutathione peroxidase deficiency in a male patient with chronic granulomatous disease.
    Matsuda I; Oka Y; Taniguchi N; Furuyama M; Kodama S; Arashima S; Mitsuyama T
    J Pediatr; 1976 Apr; 88(4 Pt 1):581-3. PubMed ID: 1255315
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Comparison of NADH and NADPH oxidase activities in granules isolated from human polymorphonuclear leukocytes with a fluorometric assay.
    Iverson D; DeChatelet LR; Spitznagel JK; Wang P
    J Clin Invest; 1977 Feb; 59(2):282-90. PubMed ID: 833275
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Characterisation of the enzyme defect in chronic granulomatous disease.
    Segal AW; Peters TJ
    Lancet; 1976 Jun; 1(7974):1363-5. PubMed ID: 59010
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Chronic granulomatous disease.
    Schmalzer EA; Miller DR
    Prog Med Genet; 1976; 1():145-84. PubMed ID: 935507
    [No Abstract]   [Full Text] [Related]  

  • 9. Genetic variants of chronic granulomatous disease: prevalence of deficiencies of two cytosolic components of the NADPH oxidase system.
    Clark RA; Malech HL; Gallin JI; Nunoi H; Volpp BD; Pearson DW; Nauseef WM; Curnutte JT
    N Engl J Med; 1989 Sep; 321(10):647-52. PubMed ID: 2770793
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Chronic granulomatous disease due to a defect in the cytosolic factor required for nicotinamide adenine dinucleotide phosphate oxidase activation.
    Curnutte JT; Berkow RL; Roberts RL; Shurin SB; Scott PJ
    J Clin Invest; 1988 Feb; 81(2):606-10. PubMed ID: 3339133
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Coregulation of NADPH oxidase activation and phosphorylation of a 48-kD protein(s) by a cytosolic factor defective in autosomal recessive chronic granulomatous disease.
    Caldwell SE; McCall CE; Hendricks CL; Leone PA; Bass DA; McPhail LC
    J Clin Invest; 1988 May; 81(5):1485-96. PubMed ID: 3366903
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Chronic granulomatous disease and glutathione peroxidase deficiency, revisited.
    Newburger PE; Malawista SE; Dinauer MC; Gelbart T; Woodman RC; Chada S; Shen Q; van Blaricom G; Quie PG; Curnutte JT
    Blood; 1994 Dec; 84(11):3861-9. PubMed ID: 7949143
    [TBL] [Abstract][Full Text] [Related]  

  • 13. NADPH-binding component of the superoxide-generating oxidase in unstimulated neutrophils and the neutrophils from the patients with chronic granulomatous disease.
    Umei T; Takeshige K; Minakami S
    Biochem J; 1987 Apr; 243(2):467-72. PubMed ID: 3632631
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Further characterization of NADPH oxidase activity of human polymorphonuclear leukocytes.
    McPhail LC; DeChatelet LR; Shirley PS
    J Clin Invest; 1976 Oct; 58(4):774-80. PubMed ID: 965484
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Deficient flavoprotein component of the NADPH-dependent O2-.-generating oxidase in the neutrophils from three male patients with chronic granulomatous disease.
    Gabig TG; Lefker BA
    J Clin Invest; 1984 Mar; 73(3):701-5. PubMed ID: 6707199
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Hydrogen peroxide production in chronic granulomatous disease. A cytochemical study of reduced pyridine nucleotide oxidases.
    Briggs RT; Karnovsky ML; Karnovsky MJ
    J Clin Invest; 1977 Jun; 59(6):1088-98. PubMed ID: 193872
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A phosphoprotein of Mr 47,000, defective in autosomal chronic granulomatous disease, copurifies with one of two soluble components required for NADPH:O2 oxidoreductase activity in human neutrophils.
    Bolscher BG; van Zwieten R; Kramer IM; Weening RS; Verhoeven AJ; Roos D
    J Clin Invest; 1989 Mar; 83(3):757-63. PubMed ID: 2537848
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cytosolic components of the respiratory burst oxidase: resolution of four components, two of which are missing in complementing types of chronic granulomatous disease.
    Curnutte JT; Scott PJ; Mayo LA
    Proc Natl Acad Sci U S A; 1989 Feb; 86(3):825-9. PubMed ID: 2915980
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Chronic granulomatous disease. Molecular genetics.
    Dinauer MC; Orkin SH
    Hematol Oncol Clin North Am; 1988 Jun; 2(2):225-40. PubMed ID: 3292508
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Molecular aspects of chronic granulomatous disease. "the NADPH oxidase complex"].
    Morel F
    Bull Acad Natl Med; 2007 Feb; 191(2):377-90; discussion 390-2. PubMed ID: 17969555
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.